Spravato · Patient retention
Retain more Spravato patients past the discontinuation cliff.
The biggest leak in an esketamine program is not acquisition, it is retention. Nearly 80% of Spravato patients discontinue within 12 months, and most of that attrition is invisible until the patient simply stops booking.
The discontinuation cliff
Esketamine requires sustained engagement through induction and maintenance, but motivation, logistics, and early mood dips push patients toward the door. Because the between-session window is unmonitored, clinics rarely see disengagement coming. The patient is counted as retained right up until the appointment they never rebook.
79.6%
discontinue within 12 months
ESKALE, France
60%
of lost patients go undetected and never rebook
70%
of lost revenue is recoverable with early detection
How Emobot improves Spravato retention
Surface disengagement early
Behavioral drift appears in the signal before the cancellations, so outreach happens while the patient is still reachable.
Prioritize the right patients
Focus retention effort on patients whose trend is sliding, rather than spreading it thin across the whole panel.
Patient-side re-engagement
In-app nudges encourage the patient to reconnect with your clinic at the moment it matters.
Quantify recoverable revenue
Pair the signal with the ROI model to see retained patients translate into protected revenue.
The evidence
- Up to $19k in lost revenue per unrecaptured patient; about 70% is recoverable with early detection.
- 75% activation when the physician recommends it.
- Validated against MADRS at r=0.89 and PHQ-9 at r=0.83.
Frequently asked questions
What is the Spravato discontinuation rate?
Real-world data from the French ESKALE cohort shows 79.6% of patients discontinue within 12 months. Much of this attrition is preventable when disengagement is detected early enough to act.
How does monitoring improve retention?
It converts invisible disengagement into an early, objective signal. Clinics use the trend to trigger timely outreach and to send patient-side nudges, recovering patients who would otherwise quietly drop off.
How much of the lost revenue is recoverable?
Roughly 70% of revenue lost to undetected attrition is recoverable with early detection, which is why retention is usually the highest-ROI lever in an esketamine program.
Go deeper in the full guide: Spravato Outcomes Tracking: Clinical Guide
See it on a real patient case.
A 30-minute demo walks through the dashboard and how Spravato patients show up in the data between visits.